CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: BIO 2016 (619) Pharma Startups (6570) Rare Diseases (230)
Alize Pharma is a group of companies specialized in the development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic and rare diseases. Its business strategy is to advance programs based on medical innovation to the cl...Show all
Company (Acquired)
Phone: +33 472 18 94 28
15, chemin du Saquin
Espace Europeen, Building G
Ecully, 69130
France
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Pegylated l-asparaginase | Aug 05, 2015 | Mar 20, 2018 | Patent |
| Modulation of ghrelin levels and ghrelin/unacylated ghrelin ratio using unacylated ghrelin | Dec 14, 2012 | Jan 24, 2017 | Patent |
| Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease | Jun 11, 2009 | Jul 02, 2013 | Patent |
| Unacylated ghrelin fragments as therapeutic agent in the treatment of obesity | Apr 29, 2011 | Nov 27, 2012 | Patent |
| Unacylated ghrelin as therapeutic agent in the treatment of metabolic disorders | May 30, 2008 | Jul 17, 2012 | Patent |
